Lipases produced by bacteria break down tear lipids and cause or exacerbate discomfort due to meibomian gland dysfunction, blepharitis or dry eye. In one embodiment, the present invention provides methods of treating and prevention further discomfort by inactivating lipases through use chlorinated solution and or their derivatives.
Toxins produced by bacteria promote infection and disease by directly damaging host tissues and by disabling the immune system. In one embodiment, the present application provides methods of treating and prevention further inflammation by inactivating toxins through use positive chlorinated ionic solution and or their derivatives.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceutical preparations for the treatment of infections; cleansing solutions for medical use; disinfectants for medical instruments; medical cleansers for skin and wounds; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for wounds; preparations for cleansing the skin for medical use; products and preparations for cleansing the skin for medical use.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Pharmaceutical preparations for the treatment of infections, namely anti-infectives; cleansing solutions for medical use, namely skin and wound cleansers; disinfectants for medical instruments; medical cleansers for skin and wounds; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for wounds; preparations for cleansing the skin for medical use
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceutical preparations for the treatment of infections; cleansing solutions for medical use; disinfectants for medical instruments; medical cleansers for skin and wounds; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for wounds; preparations for cleansing the skin for medical use; products and preparations for cleansing the skin for medical use.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INFECTIONS; CLEANSING SOLUTIONS FOR MEDICAL USE; DISINFECTANTS FOR MEDICAL INSTRUMENTS; MEDICAL CLEANSERS FOR SKIN AND WOUNDS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF EYE DISEASES AND CONDITIONS; PHARMACEUTICAL PREPARATIONS FOR WOUNDS; PREPARATIONS FOR CLEANSING THE SKIN FOR MEDICAL USE; PRODUCTS AND PREPARATIONS FOR CLEANSING THE SKIN FOR MEDICAL USE
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
HYPOCHLOROUS ACID SOLD AS A COMPONENT INGREDIENT OF PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INFECTIONS; HYPOCHLOROUS ACID SOLD AS A COMPONENT INGREDIENT OF CLEANSING SOLUTIONS FOR MEDICAL USE; HYPOCHLOROUS ACID SOLD AS A COMPONENT INGREDIENT OF DISINFECTANTS FOR MEDICAL INSTRUMENTS; HYPOCHLOROUS ACID SOLD AS A COMPONENT INGREDIENT OF MEDICAL CLEANSERS FOR SKIN AND WOUNDS; HYPOCHLOROUS ACID SOLD AS A COMPONENT INGREDIENT OF PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF EYE DISEASES AND CONDITIONS; HYPOCHLOROUS ACID SOLD AS A COMPONENT INGREDIENT OF PHARMACEUTICAL PREPARATIONS FOR WOUNDS; HYPOCHLOROUS ACID SOLD AS A COMPONENT INGREDIENT OF PREPARATIONS FOR CLEANSING THE SKIN FOR MEDICAL USE; HYPOCHLOROUS ACID SOLD AS A COMPONENT INGREDIENT OF PRODUCTS AND PREPARATIONS FOR CLEANSING THE SKIN FOR MEDICAL USE
This application describes compounds useful as anti-microbial agents, including as antibacterial, disinfectant, antifungal, germicidal or antiviral agents.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Cleansing solutions for acute use in post-elective cosmetic surgery or cosmetic dermatology; Disinfectants for medical instruments; Medical cleansers for skin and wounds; Pharmaceutical preparations for the treatment of wounds, infections, eye diseases and conditions; Products and preparations for cleansing the skin for acute use in post-elective cosmetic surgery or cosmetic dermatology; all of the foregoing sold to or through cosmetic surgeons, and not dispensed by pharmacists or retailers
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceutical preparations for the treatment of infections in animals; Medical device preparations for the treatment of infections in animals, namely, anti-infective irrigant, anti-infective cleansing solutions, non-antibiotic irrigant and wound cleanser; Pharmaceutical preparations for the treatment of wounds in animals; Medical device preparations for the treatment of wounds in animals, namely, wound dressings, anti-infective irrigant, anti-infective cleansing solutions, non-antibiotic irrigant and wound cleanser; Anti-infective cleansing solutions for veterinary use; Veterinary cleansers for animal skin care and wounds; Pharmaceutical preparations for the treatment of eye diseases and conditions in animals; Pharmaceutical preparations for cleansing skin for animals
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INFECTIONS; CLEANSING SOLUTIONS FOR MEDICAL USE; MEDICAL CLEANSERS FOR SKIN AND WOUNDS; PHARMACEUTICAL PREPARATIONS FOR WOUNDS; PREPARATIONS FOR CLEANSING THE SKIN FOR MEDICAL USE; PRODUCTS AND PREPARATIONS FOR CLEANSING THE SKIN FOR MEDICAL USE
The invention monitors the neutralization process involving hydrogen peroxide solution and a hydrogen peroxide neutralization catalyst and compares measured values with theoretical values. The system monitors the chemical reaction and notifies the user of the neutralization status. In an exemplary embodiment, the initial hydrogen peroxide solution concentration is neutralized with a palladium catalyst after a period of time. A microcontroller analyzes the measurements and displays the neutralization process results using colored LED lights and/or text or images on a LCD display. In one embodiment, an apparatus adapted for use with a cleaning solution used to clean a medical device may include a trigger, a processing device in communication with the trigger, and a display device. The processing device provides a trigger count and the display device communicates with the processing device and displays a message based on the count.
The invention monitors the neutralization process involving hydrogen peroxide solution and a hydrogen peroxide neutralization catalyst and compares measured values with theoretical values. The system monitors the chemical reaction and notifies the user of the neutralization status. In an exemplary embodiment, the initial hydrogen peroxide solution concentration is neutralized with a palladium catalyst after a period of time. A microcontroller analyzes the measurements and displays the neutralization process results using colored LED lights and/or text or images on a LCD display. In one embodiment, an apparatus adapted for use with a cleaning solution used to clean a medical device may include a trigger, a processing device in communication with the trigger, and a display device. The processing device provides a trigger count and the display device communicates with the processing device and displays a message based on the count.
B08B 3/00 - Nettoyage par des procédés impliquant l'utilisation ou la présence d'un liquide ou de vapeur d'eau
A61L 12/00 - Procédés ou appareils pour la désinfection ou la stérilisation des lentilles de contact; Accessoires à cet effet
A61L 12/12 - Procédés ou appareils pour la désinfection ou la stérilisation des lentilles de contact; Accessoires à cet effet utilisant des substances chimiques des composés non macromoléculaires contenant de l'oxygène, p.ex. peroxyde d'hydrogène ou ozone
C11D 3/39 - Percomposés organiques ou inorganiques
C11D 3/00 - Autres composés entrant dans les compositions détergentes couvertes par le groupe
The present application describes compounds of Formula I and Formula IA and as disclosed herein, that are useful as anti-microbial agents, including as antibacterial, disinfectant, antifungal, germicidal or antiviral agents.
Described herein are antimicrobial formulations or compositions comprising an N-halogenated or N,N-dihalogenated amine compound and a saccharide-based gelling agent. Methods of using such formulations, including a method of preventing or treating an infection caused by a bacterial, a microbial, a sporal, a fungal or a viral activity, are also disclosed.
The present application discloses a method of treating or preventing an infection of a nail, claw, hoof, or skin comprising administering a pharmaceutically acceptable formulation comprising hypohalite and a formulating agent to a subject in need thereof, and compositions thereof.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Pharmaceutical preparations for the treatment of infections, namely, anti-infectives; cleansing solutions for medical use, namely, disinfectants, anti-bacterial lotions, solutions and soaps for cleaning the skin and hospital environments; preparations for cleansing the skin for medical use.
The present invention relates to active bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and antiviral compounds and compositions and to new uses of these compositions in therapy. This specification also describes methods of use for the new compounds and compositions. The specification further describes methods for preparing these compounds.
C07C 309/04 - Acides sulfoniques ayant des groupes sulfo liés à des atomes de carbone acycliques d'un squelette carboné acyclique saturé contenant un seul groupe sulfo
C07C 309/13 - Acides sulfoniques ayant des groupes sulfo liés à des atomes de carbone acycliques d'un squelette carboné acyclique saturé contenant des atomes d'azote, ne faisant pas partie de groupes nitro ou nitroso, liés au squelette carboné
Disclosed herein are compositions and methods of treating or preventing an infection of the nail, claw, or hoof comprising administering to a subject a pharmaceutical composition comprising an N-halogenated or N,N-dihalogenated amine compound of the application.
A01N 33/14 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant des composés organiques de l'azote comportant des liaisons azote-halogène
The present application relates to TV-chlorinated cationic compounds of Formula I or a salt thereof, and associated compositions and methods of use as antimicrobial agents.
The present application relates to N-chlorinated oxazolidinone, hydantoin and imidazolidinone compounds of Formula (I): or pharmaceutically acceptable salts thereof, and associated compositions and methods of use as antimicrobial agents.
Disclosed herein are formulations comprising an N-halogenated or N,N- dihalogenated amine compound dispersed in a water-swellable polymer, wherein the compound is 90% stable for at least 30 days at about 25 °C. Also disclosed are methods of treating or preventing infections caused by a bacterial, a microbial, a sporal, a fungal or a viral activity using such formulations.
Disclosed herein are methods and compositions for the treatment or prophylaxis, in a mammal, of bronchopulmonary infections, obstructive pulmonary disease, cystic fibrosis, and ventilator-associated infections. The methods and compositions include a therapeutically effective amount of one or more N-halogenated or N,N-dihalogenated amines, and their analogues, derivatives, or pharmaceutically acceptable salts and esters.
The present invention relates to active bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and antiviral compounds and compositions and to new uses of these compositions in therapy. This specification also describes methods of use for the new compounds and compositions. The specification further describes methods for preparing these compounds.
Provided herein is a method for the treatment of a wound using a wound treatment regimes for treating a chronic wound, the regimen comprising; a) applying reduced pressure to the wound; and b) treating the wound with a substantially non-toxic, non-irritating organic or inorganic aganocide composition while applying reduced pressure to the wound.
A61K 31/195 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe amino
A61K 33/20 - Chlore élémentaire; Composés minéraux libérant du chlore
A61M 1/00 - Dispositifs de succion ou de pompage à usage médical; Dispositifs pour retirer, traiter ou transporter les liquides du corps; Systèmes de drainage
A61M 27/00 - Appareillage pour drainage des blessures
A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Pharmaceuticals for the treatment of infections, namely, anti-infectives; cleansing solutions for medical use, namely, disinfectants, anti-bacterial lotions, solutions and soaps for cleaning the skin and hospital environments; contact lens cleaning solutions; contact lens disinfectants; contact lens solutions; contact lens wetting solutions; disinfectants for contact lenses; disinfectants for medical instruments; eye washes; irrigating solutions for eye use; medical cleansers for skin and wounds; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for wounds.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Disinfectants for medical instruments, all of the foregoing wares available by prescription only; pharmaceutical preparations for the treatment of eye diseases and conditions, all of the foregoing wares available by prescription only; pharmaceutical preparations for wounds, all of the foregoing wares available by prescription only; medical cleansers for wounds, all of the foregoing wares available by prescription only.
Disclosed is a system that prevents the development of infection and biofilm establishment in medical devices in general, and in particular Urinary Tract Infections (UTI), including Catheter-Associated Urinary Tract Infections (CAUTI). The system comprises a medical device (such as a catheter) and an antimicrobial composition containing an antimicrobial compound. A medical device delivers the composition both to the inside and/or outside portions of the device, as well as to the inside of the bladder itself and to the urethra. Reduction or elimination of the infection may be accomplished by irrigating the medical device, bathing the bladder, or irrigating the bladder with the composition.
A61K 31/185 - Acides; Leurs anhydrides, halogénures ou sels, p.ex. acides du soufre, acides imidiques, hydrazoniques ou hydroximiques
A61K 33/00 - Préparations médicinales contenant des ingrédients actifs inorganiques
A61K 33/20 - Chlore élémentaire; Composés minéraux libérant du chlore
A61K 47/00 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p.ex. les supports ou les additifs inertes; Agents de ciblage ou de modification chimiquement liés à l’ingrédient actif
A61M 1/00 - Dispositifs de succion ou de pompage à usage médical; Dispositifs pour retirer, traiter ou transporter les liquides du corps; Systèmes de drainage
A61P 13/02 - Médicaments pour le traitement des troubles du système urinaire de l'urine ou des voies urinaires, p.ex. acidificateurs d'urine
30.
SYSTEM AND METHOD FOR THE PREVENTION AND TREATMENT OF BACTERIAL AND FUNGAL INFECTIONS INCLUDING URINARY TRACT INFECTIONS (UTI) USING A HYPOHALOUS ACID COMPOSITIONS
Disclosed is a system that prevents the development of infection and biofÊlni establishment in medical devices in general, and in particular Urinary Tract Infections (UTI), including Catheter- Associated Urinary Tract Infections (CAUTI). The system comprises of a medical device (such as a catheter) and an antimicrobial composition containing an antimicrobial compound. A medical device delivers the composition both to the inside and/or outside portions of the device, as well as to the inside of the bladder itself and to the urethra. Reduction or elimination of the infection may be accomplished by irrigating the medical device, bathing the. bladder, or irrigating the bladder with the composition.
A61K 33/00 - Préparations médicinales contenant des ingrédients actifs inorganiques
A61K 33/20 - Chlore élémentaire; Composés minéraux libérant du chlore
A61K 47/00 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p.ex. les supports ou les additifs inertes; Agents de ciblage ou de modification chimiquement liés à l’ingrédient actif
A61M 1/00 - Dispositifs de succion ou de pompage à usage médical; Dispositifs pour retirer, traiter ou transporter les liquides du corps; Systèmes de drainage
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceutical preparations for the treatment of infections; cleansing solutions for medical use; [ contact lens cleaning solutions; contact lens disinfectants; contact lens solutions; contact lens wetting solutions; disinfectants for contact lenses; ] disinfectants for medical instruments; eye washes; irrigating solutions for eye use; medical cleansers for skin and wounds; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for wounds; preparations for cleansing the skin for medical use; products and preparations for cleansing the skin for medical use
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceutical preparations for the treatment of infections; cleansing solutions for medical use; contact lens cleaning solutions; contact lens disinfectants; contact lens solutions; contact lens wetting solutions; disinfectants for contact lenses; [ disinfectants for medical instruments; eye washes; irrigating solutions for eye use; ] medical cleansers for skin and wounds; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for wounds; preparations for cleansing the skin for medical use; products and preparations for cleansing the skin for medical use
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INFECTIONS; CLEANSING SOLUTIONS FOR MEDICAL USE; [ CONTACT LENS CLEANING SOLUTIONS; CONTACT LENS DISINFECTANTS; CONTACT LENS SOLUTIONS; DISINFECTANTS FOR CONTACT LENSES; ] DISINFECTANTS FOR MEDICAL INSTRUMENTS; MEDICAL CLEANSERS FOR SKIN AND WOUNDS; [ PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF EYE DISEASES AND CONDITIONS; ] PHARMACEUTICAL PREPARATIONS FOR WOUNDS; PREPARATIONS FOR CLEANSING THE SKIN FOR MEDICAL USE; PRODUCTS AND PREPARATIONS FOR CLEANSING THE SKIN FOR MEDICAL USE
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceutical preparations for the treatment of infections, namely, for use in the nasal passage, administered in an institutional setting or for pre-surgical use for the purpose of reducing bacterial colonization
35.
N-halogenated amino acids, N,N-dihalogenated amino acids and derivatives; compositions and methods of using them
The present invention relates to active bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and antiviral compounds and compositions and to new uses of these compositions in therapy. This specification also describes methods of use for the new compounds and compositions. The specification further describes methods for preparing these compounds. FIG. 1: A dual chamber apparatus for the preparation of NNDCT on site.
C07C 309/18 - Acides sulfoniques ayant des groupes sulfo liés à des atomes de carbone acycliques d'un squelette carboné acyclique saturé contenant des groupes carboxyle liés au squelette carboné contenant des groupes amino liés au même squelette carboné
C07C 309/13 - Acides sulfoniques ayant des groupes sulfo liés à des atomes de carbone acycliques d'un squelette carboné acyclique saturé contenant des atomes d'azote, ne faisant pas partie de groupes nitro ou nitroso, liés au squelette carboné
C07C 309/14 - Acides sulfoniques ayant des groupes sulfo liés à des atomes de carbone acycliques d'un squelette carboné acyclique saturé contenant des atomes d'azote, ne faisant pas partie de groupes nitro ou nitroso, liés au squelette carboné contenant des groupes amino liés au squelette carboné
36.
N-HALOGENATED AMINO ACIDS AND N, N-DIHALOGENATED AMINO ACIDS IN COMBINATION WITH HYPOHALOUS ACIDS
The present invention relates to active bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and antiviral compounds and compositions and to new uses of these compositions in therapy. This specification also describes methods of use for the new compounds and compositions. The specification further describes methods for preparing these compounds.
A61K 31/185 - Acides; Leurs anhydrides, halogénures ou sels, p.ex. acides du soufre, acides imidiques, hydrazoniques ou hydroximiques
A61K 31/197 - Acides carboxyliques, p.ex. acide valproïque ayant un groupe amino les groupes amino et carboxyle étant liés à la même chaîne carbone acyclique, p.ex. acide gamma-aminobutyrique (GABA), bêta-alanine, acide epsilon-aminocaproïque, acide pantothénique
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; pharmaceutical preparations for the treatment of infections.
The present invention relates to active bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and antiviral compounds and compositions and to new uses of these compositions in therapy. This specification also describes methods of use for the new compounds and compositions. The specification further describes methods for preparing these compounds.
A61K 9/54 - Préparations en capsules, p.ex. de gélatine, de chocolat du type à libération prolongée ou discontinue contenant des particules distinctes avec des revêtements de différentes épaisseurs ou de différents matériaux
C07C 69/86 - Esters d'acides carboxyliques dont un groupe carboxyle estérifié est lié à un atome de carbone d'un cycle aromatique à six chaînons d'acides hydroxycarboxyliques monocycliques dont les groupes hydroxyle et les groupes carboxyle sont liés à des atomes de carbone d'un cycle aromatique à six chaînons à groupes hydroxyle estérifiés
